FUSE - Feasibility of Patient Held Sensors for Medical Emergencies

NCT ID: NCT06199310

Last Updated: 2024-01-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-30

Study Completion Date

2024-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators want to study how wearable devices can help track health changes in people when they are not feeling well. Normally, clinicians compare someone's vital signs, like heart rate, to average ranges from healthy folks. But what if clinicians compare these signs to the person's own normal when they were well? The investigators aim to check if wearable sensors can make this possible for many people. The investigators will look at heart rate differences when someone is admitted to the hospital compared to their stable days before. The investigators will see how their daily steps change a week before getting sick. This global study involves adults in emergency or acute care. Participation poses no risks, burdens, or immediate benefits to patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Rationale:

Abnormalities of vital signs are quantified by comparison with 'usual' ranges, which are those observed in resting healthy populations. It might be more appropriate to compare vital sign values of an individual that is in distress with their own usual values recorded when they were stable and well. Wearable sensors might make this possible at scale.

Objectives:

* To quantify the difference between heart rate on admission to acute care compared to the previously recorded vital signs when 24 hours and 1 week prior of the same patient.
* The change in daily steps taken by the patient in the week prior to admission to acute care
* To assess the feasibility of using heart rate data from patients' own wearable sensors.

Study design:

An asynchronous, international, multicentre observational study using the Flash Mob Research design.

Study population:

Patients aged 18 years and up who present at the Emergency Department, Acute Medical Department or Ambulatory Emergency Care with an acute complaint.

Main study parameters/endpoints:

* The difference between heart rate measured on presentation to acute care services, and measured prior when stable and well.
* The daily number of steps taken in the week prior to presentation to acute care services.
* The proportion of patients assessed for an acute complaint who have recordings of vital signs measured before they became unwell.
* A description of the population that uses devices that collect vital signs in terms of sex, age-group, digital literacy, and their severity of illness on presentation (as measured by a standard set of vital signs and frailty).
* The devices used to measure vital signs before they became unwell, and the vital signs they measure.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:

There is no burden or risk associated with participation to patients, and no immediate benefit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medical Emergencies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

A subject must meet all the following criteria:

* Have an acute presenting complaint
* Aged 18 years or older
* Uses any of the following: smart-watch, activity tracker, or other wearable monitoring device, a smart phone that collects data from other wearable device
* Ability to give informed consent

Exclusion Criteria

* Unable to give informed consent, including patients with immediately life-threatening illness
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Betsi Cadwaladr University Health Board

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Christian P Subbe

Consultant Physician, Senior Clinical Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian Subbe

Role: PRINCIPAL_INVESTIGATOR

YSBYTY Gwynedd Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ysbyty Gwynedd

Bangor, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christian P Subbe, DM

Role: CONTACT

+447771922890

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christian Subbe, DM

Role: primary

+447771922890

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRAS 321129

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bodytrak® Feasibility Study
NCT03139955 UNKNOWN